Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin to Target Arterial Events in Chronic Kidney Disease

NCT03796156 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.

NCT NCT03796156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03796156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin to Target Arterial Events in Chronic Kidney Disease
Lead sponsor
University of Southampton
Phase
Phase 3
Overall status
Terminated
Start date
February 25, 2019
Completion date
September 23, 2025
Enrollment
4,633 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, cardiovascular diseases, chronic kidney diseases